0.96 Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago

News


<< back

Shield Therapeutics (LON:STX) shareholders have endured a 89% loss from investing in the stock three years ago
Date: 2024-01-24 [news.yahoo.com]

READ THE FULL NEWS >>
×